-
Applied Workflows with c-Myc tag Peptide: Precision in Immun
2026-05-02
The c-Myc tag Peptide unlocks new levels of specificity and reproducibility in immunoassays, enabling precise displacement of c-Myc-tagged fusion proteins. Discover best practices, troubleshooting strategies, and data-backed protocol enhancements that give your transcription factor and cell biology research a competitive edge.
-
Berberine Hydrochloride Induces Tuft Cells to Counter Bone L
2026-05-01
This study identifies a gut-bone axis mechanism where berberine hydrochloride alleviates estrogen deficiency-induced bone loss by promoting intestinal tuft cell expansion through butyrate-GPR41 signaling. The findings introduce a novel therapeutic pathway for postmenopausal osteoporosis and reposition berberine sulphate as a modulator of osteoimmune and metabolic interactions.
-
Selective Autophagy Regulates IRF3 Stability and Immune Bala
2026-05-01
Wu et al. reveal that selective autophagy tightly controls the stability of the transcription factor IRF3, modulating type I interferon production and immune suppression. By dissecting the interplay between autophagic degradation and deubiquitination, the study advances understanding of innate immune signaling regulation.
-
Applied Use-Cases of the c-Myc tag Peptide in Immunoassays
2026-04-30
The c-Myc tag Peptide accelerates high-specificity immunoassays by enabling precise displacement of c-Myc-tagged fusion proteins and robust inhibition of anti-c-Myc antibody binding. Leverage protocol optimization and troubleshooting strategies to maximize reproducibility in advanced transcription factor and cell signaling workflows.
-
p-Cresyl Sulfate in Endothelial Dysfunction: Advanced Assays
2026-04-30
Leverage p-Cresyl sulfate as a precision tool for modeling endothelial dysfunction and vascular calcification in chronic kidney disease. This guide details experimental workflows, protocol optimizations, and actionable troubleshooting, translating recent breakthroughs into robust, reproducible research strategies.
-
0.4% Trypan Blue Solution: Practical Parameters & QC Guidanc
2026-04-29
0.4% Trypan Blue Solution enables researchers to distinguish between live and dead cells efficiently, supporting accurate cell viability measurement and cell counting in cell culture and cytotoxicity workflows. This product is not suitable for diagnostic or clinical use and should be applied strictly within research contexts where membrane integrity-based live/dead discrimination is required.
-
Surfactant-Derived LNPs Enable mRNA Delivery to Macrophages
2026-04-29
This study introduces a dual-component lipid nanoparticle system, leveraging surfactant-derived ionizable lipids to efficiently deliver mRNA to hard-to-transfect macrophages. The innovation enhances mRNA protection and cellular uptake, offering a promising platform for targeted genetic engineering in immunological research.
-
First-in-Class Small Molecule LAG-3 Inhibitors: Discovery an
2026-04-28
This study reports the discovery of the first small molecule inhibitors targeting lymphocyte activation gene 3 (LAG-3), a key immune checkpoint in cancer. Through focused screening and SAR-by-catalog strategies, the authors identified dual LAG-3/MHCII and LAG-3/FGL1 inhibitors with promising biochemical and cellular activity, paving the way for new cancer immunotherapy approaches.
-
PFOS Triggers Ferroptosis and ER Stress in Renal Cell Injury
2026-04-28
This study elucidates how perfluorooctane sulfonate (PFOS), a persistent environmental pollutant, injures human kidney tubular cells by simultaneously activating ferroptosis and endoplasmic reticulum (ER) stress pathways. These findings clarify mechanistic links between environmental exposure and renal toxicity, highlighting research opportunities for ER stress modulation in kidney injury models.
-
Evaluating Antiprotozoal Agents Against Soft Tunic Syndrome
2026-04-27
This study systematically assesses the efficacy of various antiprotozoal compounds, including Sulfamonomethoxine (SMM), against Azumiobodo hoyamushi—the causative agent of soft tunic syndrome in Halocynthia roretzi. The findings clarify relative drug potencies and inform evidence-based strategies for disease management in aquaculture.
-
X-press Tag Peptide: Advancing Translational Protein Science
2026-04-27
Explore how the X-press Tag Peptide empowers mechanistic, post-translational modification research and translational workflows. This thought-leadership article integrates evidence from recent molecular oncology studies and expert protocol guidance to help researchers optimize affinity purification, detection, and functional analysis of recombinant proteins involved in complex signaling, such as mTORC1. Strategic recommendations and protocol parameters are presented to elevate reproducibility and clinical relevance.
-
c-Myc tag Peptide: Mechanistic Precision for Translational R
2026-04-26
This article explores the role of the c-Myc tag peptide as a strategic tool for translational scientists, blending mechanistic insights into transcription factor regulation with actionable guidance for immunoassay optimization. By integrating recent advances in autophagy-mediated transcription factor control and highlighting emerging best practices, we reposition the c-Myc tag peptide as a critical enabler for next-generation research in oncology, immunology, and cell biology.
-
PP2A-Mediated Autophagy Drives Drug Resistance in C. albican
2026-04-25
This study uncovers the pivotal role of protein phosphatase 2A (PP2A) in regulating drug resistance in Candida albicans biofilms via autophagy induction, specifically through phosphorylation of ATG proteins. The findings highlight PP2A-autophagy interplay as a mechanistic driver of antifungal resistance and suggest new targets for overcoming persistent biofilm-related infections.
-
Pharmacokinetic Variability of CSBTA in MASH: Insights from
2026-04-24
This study systematically characterizes how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in mice. The findings highlight the importance of disease status, transporter modulation, and dosing regimen in optimizing CSBTA-based interventions for chronic liver disease.
-
Hematoxylin and Eosin Staining Kit: Workflow and QC Guide
2026-04-24
The Hematoxylin and Eosin Staining Kit (SKU: K1142) addresses the need for reproducible and efficient tissue morphology visualization in research settings. Suitable for both paraffin-embedded and frozen tissue section staining, it offers ready-to-use reagents for consistent nuclear and cytoplasmic staining. This kit is not intended for clinical diagnostics or medical decision-making.